U.S. Markets closed

Cytokinetics, Incorporated (CYTK)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
12.550.00 (0.00%)
At close: 4:00PM EDT

12.55 0.00 (0.00%)
After hours: 4:27PM EDT

People also watch
Full screen
Previous Close12.55
Bid0.00 x 0
Ask0.00 x 0
Day's Range12.45 - 12.75
52 Week Range8.51 - 17.20
Avg. Volume520,553
Market Cap673.52M
PE Ratio (TTM)169.59
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    ETFs with exposure to Cytokinetics, Inc. : August 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents11 days ago

    Edited Transcript of CYTK earnings conference call or presentation 2-Aug-17 8:30pm GMT

    Q2 2017 Cytokinetics Inc Earnings Call

  • Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017
    Capital Cube12 days ago

    Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytokinetics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cytokinetics, Inc. – Ligand Pharmaceuticals Incorporated, Trevena, Inc., Acorda Therapeutics, Inc., ArQule, Inc. and Amgen Inc. (LGND-US, TRVN-US, ACOR-US, ARQL-US and AMGN-US) that have also reported for this period. ... Read more (Read more...)